Medtronic PLC (MDT)

Medtronic plc is a healthcare company focused on device-based medical therapies for hospitals, physicians, clinicians, and patients in the United States, Ireland, and other international markets. Its Cardiovascular Portfolio includes implantable pacemakers, defibrillators, cardiac resynchronization therapy devices, ablation products, insertable cardiac monitoring systems, TYRX products, remote monitoring tools, and therapies for structural heart and coronary conditions. The Neuroscience Portfolio covers medical devices and implants, biologic solutions, spinal cord stimulation, brain modulation, drug infusion systems, interventional products, and nerve ablation systems. The Medical Surgical Portfolio provides surgical stapling, vessel sealing, wound closure, electrosurgery, robotic-assisted surgery, video and analytics technology, and products for hernia, gynecology, gastrointestinal, hepatologic, monitoring, and airway care. Its Diabetes Operating Unit supplies insulin pumps, consumables, glucose monitoring systems, sensors, and the InPen smart insulin pen. Founded in 1949, Medtronic is headquartered in Galway, Ireland, and its common stock trades on the NYSE under the symbol MDT.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.